157 related articles for article (PubMed ID: 7522642)
1. Apoptosis and macrophage-mediated deletion of precursor B cells in the bone marrow of E mu-myc transgenic mice.
Jacobsen KA; Prasad VS; Sidman CL; Osmond DG
Blood; 1994 Oct; 84(8):2784-94. PubMed ID: 7522642
[TBL] [Abstract][Full Text] [Related]
2. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
3. Dynamics and localization of early B-lymphocyte precursor cells (pro-B cells) in the bone marrow of scid mice.
Osmond DG; Kim N; Manoukian R; Phillips RA; Rico-Vargas SA; Jacobsen K
Blood; 1992 Apr; 79(7):1695-703. PubMed ID: 1373084
[TBL] [Abstract][Full Text] [Related]
4. Cell populations during tumorigenesis in Eu-myc transgenic mice.
Sidman CL; Shaffer DJ; Jacobsen K; Vargas SR; Osmond DG
Leukemia; 1993 Jun; 7(6):887-95. PubMed ID: 8501983
[TBL] [Abstract][Full Text] [Related]
5. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
6. Prelymphomatous B cell hyperplasia in the bone marrow of interleukin-7 transgenic mice: precursor B cell dynamics, microenvironmental organization and osteolysis.
Valenzona HO; Pointer R; Ceredig R; Osmond DG
Exp Hematol; 1996 Nov; 24(13):1521-9. PubMed ID: 8950236
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell survival during B lymphopoiesis: increased pre-B cell apoptosis in CD24-transgenic mouse bone marrow.
Lu L; Chappel MS; Humphries RK; Osmond DG
Eur J Immunol; 2000 Sep; 30(9):2686-91. PubMed ID: 11009103
[TBL] [Abstract][Full Text] [Related]
8. Microenvironmental organization and stromal cell associations of B lymphocyte precursor cells in mouse bone marrow.
Jacobsen K; Osmond DG
Eur J Immunol; 1990 Nov; 20(11):2395-404. PubMed ID: 2253679
[TBL] [Abstract][Full Text] [Related]
9. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
10. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.
Alexander WS; Schrader JW; Adams JM
Mol Cell Biol; 1987 Apr; 7(4):1436-44. PubMed ID: 3037318
[TBL] [Abstract][Full Text] [Related]
11. Immunologic competence of B cells subjected to constitutive c-myc oncogene expression in immunoglobulin heavy chain enhancer myc transgenic mice.
Vaux DL; Adams JM; Alexander WS; Pike BL
J Immunol; 1987 Dec; 139(11):3854-60. PubMed ID: 2445821
[TBL] [Abstract][Full Text] [Related]
12. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
[TBL] [Abstract][Full Text] [Related]
14. Changes in frequencies of clonable pre B cells during life in different lymphoid organs of mice.
Rolink A; Haasner D; Nishikawa S; Melchers F
Blood; 1993 May; 81(9):2290-300. PubMed ID: 7683215
[TBL] [Abstract][Full Text] [Related]
15. Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy.
Langdon WY; Harris AW; Cory S
Oncogene Res; 1988; 3(3):271-9. PubMed ID: 3144697
[TBL] [Abstract][Full Text] [Related]
16. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis during B lymphopoiesis in mouse bone marrow.
Lu L; Osmond DG
J Immunol; 1997 Jun; 158(11):5136-45. PubMed ID: 9164929
[TBL] [Abstract][Full Text] [Related]
18. IL-1 as systemic modifier of B lymphopoiesis. Recombinant IL-1 alpha binds to stromal cells and sinusoid endothelium in bone marrow and precursor B cell dynamics.
Fauteux LJ; Osmond DG
J Immunol; 1996 Apr; 156(7):2376-83. PubMed ID: 8786294
[TBL] [Abstract][Full Text] [Related]
19. Normal serum immunoglobulins influence the numbers of bone marrow pre-B and B cells.
Sundblad A; Marcos M; Huetz F; Freitas A; Heusser C; Portnoï D; Coutinho A
Eur J Immunol; 1991 May; 21(5):1155-61. PubMed ID: 1828029
[TBL] [Abstract][Full Text] [Related]
20. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
